Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.05 Billion | 8.69 Billion | 8.02 Billion | 6.51 Billion | 5.72 Billion | 4.76 Billion |
| Cost of Revenue | 5.45 Billion | 4.72 Billion | 3.95 Billion | 3.57 Billion | 3.19 Billion | 2.74 Billion |
| Gross Profit | 4.59 Billion | 3.96 Billion | 4.06 Billion | 2.94 Billion | 2.53 Billion | 2.02 Billion |
| Operating Expenses | 1.3 Billion | 1.1 Billion | 1.29 Billion | 1.1 Billion | 948.03 Million | 769.2 Million |
| Selling, General and Administrative Expenses | 1.07 Billion | 534.38 Million | 715.32 Million | 718.18 Million | 570.45 Million | 443.59 Million |
| Research and Development Expenses | 232.35 Million | 230.03 Million | 199.51 Million | 97.55 Million | 119.43 Million | 100.81 Million |
| Other Expenses | -7.63 Million | 341.1 Million | 376.26 Million | 293.7 Million | 258.14 Million | 7.46 Million |
| Cost and Expenses | 6.66 Billion | 5.83 Billion | 5.24 Billion | 4.67 Billion | 4.13 Billion | 3.51 Billion |
| Operating Income | 3.39 Billion | 2.97 Billion | 2.87 Billion | 1.97 Billion | 1.63 Billion | 1.32 Billion |
| Interest Expense | 37.3 Million | 38 Million | 32.89 Million | 27.38 Million | 31.13 Million | 27.64 Million |
| Income Tax Expense | 517.77 Million | 454.75 Million | 405 Million | 289.54 Million | 257.65 Million | 198.76 Million |
| Earnings before Tax | 3.36 Billion | 2.97 Billion | 2.86 Billion | 1.97 Billion | 1.64 Billion | 1.32 Billion |
| Net Income | 2.79 Billion | 2.47 Billion | 2.43 Billion | 1.67 Billion | 1.37 Billion | 1.14 Billion |
| Earnings Per Share Basic | 4.64 | 4.10 | 4.03 | 2.77 | 2.28 | 1.89 |
| Earnings Per Share Diluted | 4.64 | 4.10 | 4.03 | 2.77 | 2.28 | 1.89 |
| Weighted Average Shares Outstanding | 602.87 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 602.87 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million | 604.72 Million |
| Gross Margin | 0.46 | 0.46 | 0.51 | 0.45 | 0.44 | 0.42 |
| EBIT Margin | 0.36 | 0.36 | 0.38 | 0.32 | 0.30 | 0.30 |
| Profit Margin | 0.28 | 0.28 | 0.30 | 0.26 | 0.24 | 0.24 |
| EBITDA | 3.57 Billion | 3.12 Billion | 3.04 Billion | 2.07 Billion | 1.73 Billion | 1.33 Billion |
| Earnings Before Tax Margin | 0.34 | 0.34 | 0.36 | 0.30 | 0.29 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.79 Billion | 2.47 Billion | 3.14 Billion | 2.44 Billion | 9.97 Billion | 2.55 Billion |
| Cost of Revenue | 1.48 Billion | 1.92 Billion | 1.67 Billion | 1.46 Billion | 5.45 Billion | 1.24 Billion |
| Gross Profit | 1.31 Billion | 557.66 Million | 1.47 Billion | 978.66 Million | 4.51 Billion | 1.3 Billion |
| Operating Expenses | 217.65 Million | 1.59 Billion | 333.65 Million | 551.72 Million | 1.29 Billion | 313.95 Million |
| Selling, General and Administrative Expenses | 353.95 Million | 243.53 Million | 243.53 Million | 506.88 Million | - | 363.64 Million |
| Research and Development Expenses | 28.78 Million | 88.8 Million | 88.8 Million | 41.42 Million | - | 64.01 Million |
| Other Expenses | -165.09 Million | -1.59 Billion | -1.3 Million | -3.41 Million | -7.63 Million | 19.11 Million |
| Cost and Expenses | 1.7 Billion | 1.59 Billion | 2 Billion | 2.02 Billion | 6.74 Billion | 1.56 Billion |
| Operating Income | 1.12 Billion | 884.88 Million | 1.14 Billion | 426.94 Million | 3.22 Billion | 1.03 Billion |
| Interest Expense | 9.17 Million | 9.23 Million | 9.74 Million | 9.47 Million | 37.3 Million | 9.55 Million |
| Income Tax Expense | 156.37 Million | 162.73 Million | 171.86 Million | 84.36 Million | 517.77 Million | 159.23 Million |
| Earnings before Tax | 1.12 Billion | 883.7 Million | 1.16 Billion | 501.6 Million | 3.4 Billion | 1.03 Billion |
| Net Income | 965.14 Million | 747.03 Million | 974.5 Million | 392.7 Million | 2.79 Billion | 863.81 Million |
| Earnings Per Share Basic | 1.60 | 1.20 | 1.62 | 0.65 | - | 1.43 |
| Earnings Per Share Diluted | 1.60 | 1.20 | 1.62 | 0.65 | - | 1.43 |
| Weighted Average Shares Outstanding | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million | 603.31 Million |
| Gross Margin | 0.47 | 0.22 | 0.47 | 0.40 | 0.45 | 0.51 |
| EBIT Margin | 0.41 | 0.36 | 0.38 | 0.19 | - | 0.41 |
| Profit Margin | 0.34 | 0.30 | 0.31 | 0.16 | 0.28 | 0.34 |
| EBITDA | 1.13 Billion | 884.88 Million | 1.19 Billion | 463.85 Million | - | 1.05 Billion |
| Earnings Before Tax Margin | 0.40 | 0.36 | 0.36 | 0.17 | 0.32 | 0.41 |
600379
BWB
PGTK
ECC-B
GTCH
TWLO